Keywords: Boehringer Ingelheim, AIDS drugs, Pricing, AHF, Low income patients

Boehringer Ingelheim accused of refusing to increase access to AIDS drugs for low-income patients

Article | 21 January 2011

Print This

Despite a growing national AIDS drug crisis in the USA, independent German pharmaceutical major Boehringer Ingelheim “has steadfastly refused ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in